Review



cck 8 reagent  (Dojindo Labs)


Bioz Verified Symbol Dojindo Labs is a verified supplier
Bioz Manufacturer Symbol Dojindo Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Dojindo Labs cck 8 reagent
    PLXNC1 promotes the proliferation, migration, and invasion of colorectal cancer (CRC) cells in vitro. (A) qRT-PCR analysis was conducted to examine the knockdown efficiency of PLXNC1 in the negative control (NC)-siRNA- or PLXNC1-siRNA-transfected CRC cells. NC-siRNA was used as a negative control. GAPDH was a normalization control. <t>(B)</t> <t>CCK-8</t> assay was performed to assay the viability of control and PLXNC1-silenced CRC cells. (C) After 48 h of transfection with NC-siRNA or PLXNC1-siRNA, the migration of CRC cells in Transwell chambers was determined. (D) After 48 h of transfection with NC-siRNA or PLXNC1-siRNA, CRC cells invading the Matrigel in Transwell chambers were performed. Note: Scale bars = 200 μm. (E) Representative images of EdU-stained (red) cells and the quantification of cell proliferation ratio normalized to Hoechst-stained (blue) cells. Scale bars = 75 μm. (F) qRT-PCR data of the PLXNC1 expression in LoVo cells following transfection with PLXNC1 plasmids or controls. GAPDH was a normalization control. (G) CCK-8 assay results show the viability of LoVo cells following transfection with PLXNC1 plasmids or controls. (H, I) Transwell assay was employed to count the number of migrated (H) and invaded (I) LoVo cells following transfection with PLXNC1 plasmids or controls. ∗∗∗ p < 0.001; ∗∗ p < 0.01, and ∗ p < 0.05.
    Cck 8 Reagent, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 99/100, based on 59887 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cck-8+reagent/Cell+Counting+Kit-8/pmc13090551-93-0-4
    Average 99 stars, based on 59887 article reviews
    cck 8 reagent - by Bioz Stars, 2026-09
    99/100 stars

    Images

    1) Product Images from "Identification of PLXNC1 as a novel biomarker for consensus molecular subtype 4 in colorectal cancer"

    Article Title: Identification of PLXNC1 as a novel biomarker for consensus molecular subtype 4 in colorectal cancer

    Journal: Genes & Diseases

    doi: 10.1016/j.gendis.2025.101974

    PLXNC1 promotes the proliferation, migration, and invasion of colorectal cancer (CRC) cells in vitro. (A) qRT-PCR analysis was conducted to examine the knockdown efficiency of PLXNC1 in the negative control (NC)-siRNA- or PLXNC1-siRNA-transfected CRC cells. NC-siRNA was used as a negative control. GAPDH was a normalization control. (B) CCK-8 assay was performed to assay the viability of control and PLXNC1-silenced CRC cells. (C) After 48 h of transfection with NC-siRNA or PLXNC1-siRNA, the migration of CRC cells in Transwell chambers was determined. (D) After 48 h of transfection with NC-siRNA or PLXNC1-siRNA, CRC cells invading the Matrigel in Transwell chambers were performed. Note: Scale bars = 200 μm. (E) Representative images of EdU-stained (red) cells and the quantification of cell proliferation ratio normalized to Hoechst-stained (blue) cells. Scale bars = 75 μm. (F) qRT-PCR data of the PLXNC1 expression in LoVo cells following transfection with PLXNC1 plasmids or controls. GAPDH was a normalization control. (G) CCK-8 assay results show the viability of LoVo cells following transfection with PLXNC1 plasmids or controls. (H, I) Transwell assay was employed to count the number of migrated (H) and invaded (I) LoVo cells following transfection with PLXNC1 plasmids or controls. ∗∗∗ p < 0.001; ∗∗ p < 0.01, and ∗ p < 0.05.
    Figure Legend Snippet: PLXNC1 promotes the proliferation, migration, and invasion of colorectal cancer (CRC) cells in vitro. (A) qRT-PCR analysis was conducted to examine the knockdown efficiency of PLXNC1 in the negative control (NC)-siRNA- or PLXNC1-siRNA-transfected CRC cells. NC-siRNA was used as a negative control. GAPDH was a normalization control. (B) CCK-8 assay was performed to assay the viability of control and PLXNC1-silenced CRC cells. (C) After 48 h of transfection with NC-siRNA or PLXNC1-siRNA, the migration of CRC cells in Transwell chambers was determined. (D) After 48 h of transfection with NC-siRNA or PLXNC1-siRNA, CRC cells invading the Matrigel in Transwell chambers were performed. Note: Scale bars = 200 μm. (E) Representative images of EdU-stained (red) cells and the quantification of cell proliferation ratio normalized to Hoechst-stained (blue) cells. Scale bars = 75 μm. (F) qRT-PCR data of the PLXNC1 expression in LoVo cells following transfection with PLXNC1 plasmids or controls. GAPDH was a normalization control. (G) CCK-8 assay results show the viability of LoVo cells following transfection with PLXNC1 plasmids or controls. (H, I) Transwell assay was employed to count the number of migrated (H) and invaded (I) LoVo cells following transfection with PLXNC1 plasmids or controls. ∗∗∗ p < 0.001; ∗∗ p < 0.01, and ∗ p < 0.05.

    Techniques Used: Migration, In Vitro, Quantitative RT-PCR, Knockdown, Negative Control, Transfection, Control, CCK-8 Assay, Staining, Expressing, Transwell Assay

    Related Articles

    CCK-8 Assay:

    Article Title: Clinical value of free ubiquitin in the identification of diabetic nephropathy in patients with type 2 diabetes mellitus and preliminary exploration of its protective effect
    Article Snippet: The cells were incubated at 37 °C for 0 h, 6 h, 12 h and 24 h, and then 25 μL of CCK-8 reagent (Dojindo Molecular Technologies, Kumamoto, Japan) was added to cells for a 2-h incubation.

    Article Title: Matrix stiffness regulates glucose-6-phosphate dehydrogenase expression to mediate sorafenib resistance in hepatocellular carcinoma through the ITGB1-PI3K/AKT pathway
    Article Snippet: After 48 h, a CCK-8 reagent (10 μL/well, CCK-8, Dojindo, Japan) mixed with serum-free medium (90 μL/well) was added to each well.

    Article Title: Piezo1 participates in the tension-driven osteogenic differentiation of periodontal ligament stem cells
    Article Snippet: Samples of hPDLSCs were incubated with CCK-8 (Dojindo, Japan) reagent in the dark in an incubator for 2 h. The absorbances at 450 nm were measured using a microplate reader.

    Article Title: NIR light-propelled Janus Polydopamine@Mesoporous silica gene delivery nanomotor for the enhanced gene treatment of critical limb ischemia
    Article Snippet: Following that, a volume of 10 μL of CCK-8 reagent (Dojindo, Kumamoto, Japan) was introduced to each well and left to incubate with the cells for a period of 4 h. The optical density (OD) was estimated at 490 nm with a Varioskan Flash microplate reader (Thermo Fisher Scientific Inc., Waltham, MA, USA).

    Article Title: Developing an NT3-loaded exosomal biodegradable conductive hydrogel combined with EA for targeted treatment of spinal cord injury
    Article Snippet: Being a part of the tests after exposure, CCK-8 reagent (20 μL) purchased from Dojindo Laboratories was added and incubated for 2h at 37 °C, 5 % CO2.

    Article Title: Design of a Thermoresponsive, Scalable, and Robust Recombinant Protein-Based Bioadhesive by Combining Elastin-like Polypeptide with Barnacle Cement Protein.
    Article Snippet: Protein-based adhesives hold great promise as biomedical adhesives (bioadhesives) due to their exceptional biocompatibility and biodegradability.. However, their wet adhesion abilities remain a significant challenge.. Marine adhesive proteins (MAPs), a class of proteins renowned for their superior underwater adhesion abilities, provide critical inspiration for the design of robust protein-based bioadhesives.

    Article Title: Bioinformatics Analysis Identifies a Potential Key Gene in the Pathogenesis of Pulmonary Hypertension‐HSPH1
    Article Snippet: After treatment under specific conditions, add 10 μL of CCK‐8 reagent (Dojindo, Japan) to each well and incubate at 37°C for 2 h in the dark.

    Article Title: CALR promotes corneal epithelial cell proliferation and migration through Wnt7a.
    Article Snippet: After 24, 48, and 72 h culture, 10 μl of CCK-8 reagent (Dojindo, China) was added and continued to be cultured for 2 h. Cell viability was then calculated by measuring OD value at 450 nm using a microplate reader.

    Incubation:

    Article Title: Clinical value of free ubiquitin in the identification of diabetic nephropathy in patients with type 2 diabetes mellitus and preliminary exploration of its protective effect
    Article Snippet: The cells were incubated at 37 °C for 0 h, 6 h, 12 h and 24 h, and then 25 μL of CCK-8 reagent (Dojindo Molecular Technologies, Kumamoto, Japan) was added to cells for a 2-h incubation.

    Article Title: Matrix stiffness regulates glucose-6-phosphate dehydrogenase expression to mediate sorafenib resistance in hepatocellular carcinoma through the ITGB1-PI3K/AKT pathway
    Article Snippet: After 48 h, a CCK-8 reagent (10 μL/well, CCK-8, Dojindo, Japan) mixed with serum-free medium (90 μL/well) was added to each well.

    Article Title: Piezo1 participates in the tension-driven osteogenic differentiation of periodontal ligament stem cells
    Article Snippet: Samples of hPDLSCs were incubated with CCK-8 (Dojindo, Japan) reagent in the dark in an incubator for 2 h. The absorbances at 450 nm were measured using a microplate reader.

    Article Title: NIR light-propelled Janus Polydopamine@Mesoporous silica gene delivery nanomotor for the enhanced gene treatment of critical limb ischemia
    Article Snippet: Following that, a volume of 10 μL of CCK-8 reagent (Dojindo, Kumamoto, Japan) was introduced to each well and left to incubate with the cells for a period of 4 h. The optical density (OD) was estimated at 490 nm with a Varioskan Flash microplate reader (Thermo Fisher Scientific Inc., Waltham, MA, USA).

    Article Title: Developing an NT3-loaded exosomal biodegradable conductive hydrogel combined with EA for targeted treatment of spinal cord injury
    Article Snippet: Being a part of the tests after exposure, CCK-8 reagent (20 μL) purchased from Dojindo Laboratories was added and incubated for 2h at 37 °C, 5 % CO2.

    Article Title: Design of a Thermoresponsive, Scalable, and Robust Recombinant Protein-Based Bioadhesive by Combining Elastin-like Polypeptide with Barnacle Cement Protein.
    Article Snippet: Protein-based adhesives hold great promise as biomedical adhesives (bioadhesives) due to their exceptional biocompatibility and biodegradability.. However, their wet adhesion abilities remain a significant challenge.. Marine adhesive proteins (MAPs), a class of proteins renowned for their superior underwater adhesion abilities, provide critical inspiration for the design of robust protein-based bioadhesives.

    Article Title: Bioinformatics Analysis Identifies a Potential Key Gene in the Pathogenesis of Pulmonary Hypertension‐HSPH1
    Article Snippet: After treatment under specific conditions, add 10 μL of CCK‐8 reagent (Dojindo, Japan) to each well and incubate at 37°C for 2 h in the dark.

    Article Title: CALR promotes corneal epithelial cell proliferation and migration through Wnt7a.
    Article Snippet: After 24, 48, and 72 h culture, 10 μl of CCK-8 reagent (Dojindo, China) was added and continued to be cultured for 2 h. Cell viability was then calculated by measuring OD value at 450 nm using a microplate reader.

    Cell Culture:

    Article Title: Clinical value of free ubiquitin in the identification of diabetic nephropathy in patients with type 2 diabetes mellitus and preliminary exploration of its protective effect
    Article Snippet: The cells were incubated at 37 °C for 0 h, 6 h, 12 h and 24 h, and then 25 μL of CCK-8 reagent (Dojindo Molecular Technologies, Kumamoto, Japan) was added to cells for a 2-h incubation.

    Article Title: Matrix stiffness regulates glucose-6-phosphate dehydrogenase expression to mediate sorafenib resistance in hepatocellular carcinoma through the ITGB1-PI3K/AKT pathway
    Article Snippet: After 48 h, a CCK-8 reagent (10 μL/well, CCK-8, Dojindo, Japan) mixed with serum-free medium (90 μL/well) was added to each well.

    Article Title: Piezo1 participates in the tension-driven osteogenic differentiation of periodontal ligament stem cells
    Article Snippet: Samples of hPDLSCs were incubated with CCK-8 (Dojindo, Japan) reagent in the dark in an incubator for 2 h. The absorbances at 450 nm were measured using a microplate reader.

    Article Title: NIR light-propelled Janus Polydopamine@Mesoporous silica gene delivery nanomotor for the enhanced gene treatment of critical limb ischemia
    Article Snippet: Following that, a volume of 10 μL of CCK-8 reagent (Dojindo, Kumamoto, Japan) was introduced to each well and left to incubate with the cells for a period of 4 h. The optical density (OD) was estimated at 490 nm with a Varioskan Flash microplate reader (Thermo Fisher Scientific Inc., Waltham, MA, USA).

    Article Title: Developing an NT3-loaded exosomal biodegradable conductive hydrogel combined with EA for targeted treatment of spinal cord injury
    Article Snippet: Being a part of the tests after exposure, CCK-8 reagent (20 μL) purchased from Dojindo Laboratories was added and incubated for 2h at 37 °C, 5 % CO2.

    Article Title: Design of a Thermoresponsive, Scalable, and Robust Recombinant Protein-Based Bioadhesive by Combining Elastin-like Polypeptide with Barnacle Cement Protein.
    Article Snippet: Protein-based adhesives hold great promise as biomedical adhesives (bioadhesives) due to their exceptional biocompatibility and biodegradability.. However, their wet adhesion abilities remain a significant challenge.. Marine adhesive proteins (MAPs), a class of proteins renowned for their superior underwater adhesion abilities, provide critical inspiration for the design of robust protein-based bioadhesives.

    Article Title: Bioinformatics Analysis Identifies a Potential Key Gene in the Pathogenesis of Pulmonary Hypertension‐HSPH1
    Article Snippet: After treatment under specific conditions, add 10 μL of CCK‐8 reagent (Dojindo, Japan) to each well and incubate at 37°C for 2 h in the dark.

    Article Title: CALR promotes corneal epithelial cell proliferation and migration through Wnt7a.
    Article Snippet: After 24, 48, and 72 h culture, 10 μl of CCK-8 reagent (Dojindo, China) was added and continued to be cultured for 2 h. Cell viability was then calculated by measuring OD value at 450 nm using a microplate reader.



    Similar Products

    99
    MedChemExpress cck 8 reagent
    Cck 8 Reagent, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cck-8+reagent/Cell+Counting+Kit-8/10__1016_slash_j__apsb__2026__08__007-107-17-19
    Average 99 stars, based on 1 article reviews
    cck 8 reagent - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    MedChemExpress cell counting kit-8
    Cell Counting Kit 8, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cck-8+reagent/Cell+Counting+Kit-8/custom%40hy-k0301%4042142699
    Average 99 stars, based on 1 article reviews
    cell counting kit-8 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    Dojindo Labs cck 8 reagent
    PLXNC1 promotes the proliferation, migration, and invasion of colorectal cancer (CRC) cells in vitro. (A) qRT-PCR analysis was conducted to examine the knockdown efficiency of PLXNC1 in the negative control (NC)-siRNA- or PLXNC1-siRNA-transfected CRC cells. NC-siRNA was used as a negative control. GAPDH was a normalization control. <t>(B)</t> <t>CCK-8</t> assay was performed to assay the viability of control and PLXNC1-silenced CRC cells. (C) After 48 h of transfection with NC-siRNA or PLXNC1-siRNA, the migration of CRC cells in Transwell chambers was determined. (D) After 48 h of transfection with NC-siRNA or PLXNC1-siRNA, CRC cells invading the Matrigel in Transwell chambers were performed. Note: Scale bars = 200 μm. (E) Representative images of EdU-stained (red) cells and the quantification of cell proliferation ratio normalized to Hoechst-stained (blue) cells. Scale bars = 75 μm. (F) qRT-PCR data of the PLXNC1 expression in LoVo cells following transfection with PLXNC1 plasmids or controls. GAPDH was a normalization control. (G) CCK-8 assay results show the viability of LoVo cells following transfection with PLXNC1 plasmids or controls. (H, I) Transwell assay was employed to count the number of migrated (H) and invaded (I) LoVo cells following transfection with PLXNC1 plasmids or controls. ∗∗∗ p < 0.001; ∗∗ p < 0.01, and ∗ p < 0.05.
    Cck 8 Reagent, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cck-8+reagent/Cell+Counting+Kit-8/pmc13090551-93-0-4
    Average 99 stars, based on 1 article reviews
    cck 8 reagent - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    86
    Yeasen Biotechnology cell count kit 8 cck 8 reagent
    PLXNC1 promotes the proliferation, migration, and invasion of colorectal cancer (CRC) cells in vitro. (A) qRT-PCR analysis was conducted to examine the knockdown efficiency of PLXNC1 in the negative control (NC)-siRNA- or PLXNC1-siRNA-transfected CRC cells. NC-siRNA was used as a negative control. GAPDH was a normalization control. <t>(B)</t> <t>CCK-8</t> assay was performed to assay the viability of control and PLXNC1-silenced CRC cells. (C) After 48 h of transfection with NC-siRNA or PLXNC1-siRNA, the migration of CRC cells in Transwell chambers was determined. (D) After 48 h of transfection with NC-siRNA or PLXNC1-siRNA, CRC cells invading the Matrigel in Transwell chambers were performed. Note: Scale bars = 200 μm. (E) Representative images of EdU-stained (red) cells and the quantification of cell proliferation ratio normalized to Hoechst-stained (blue) cells. Scale bars = 75 μm. (F) qRT-PCR data of the PLXNC1 expression in LoVo cells following transfection with PLXNC1 plasmids or controls. GAPDH was a normalization control. (G) CCK-8 assay results show the viability of LoVo cells following transfection with PLXNC1 plasmids or controls. (H, I) Transwell assay was employed to count the number of migrated (H) and invaded (I) LoVo cells following transfection with PLXNC1 plasmids or controls. ∗∗∗ p < 0.001; ∗∗ p < 0.01, and ∗ p < 0.05.
    Cell Count Kit 8 Cck 8 Reagent, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cck-8+reagent/8+cck/pm42310756-40-9-16
    Average 86 stars, based on 1 article reviews
    cell count kit 8 cck 8 reagent - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Yeasen Biotechnology cck 8 reagent
    PLXNC1 promotes the proliferation, migration, and invasion of colorectal cancer (CRC) cells in vitro. (A) qRT-PCR analysis was conducted to examine the knockdown efficiency of PLXNC1 in the negative control (NC)-siRNA- or PLXNC1-siRNA-transfected CRC cells. NC-siRNA was used as a negative control. GAPDH was a normalization control. <t>(B)</t> <t>CCK-8</t> assay was performed to assay the viability of control and PLXNC1-silenced CRC cells. (C) After 48 h of transfection with NC-siRNA or PLXNC1-siRNA, the migration of CRC cells in Transwell chambers was determined. (D) After 48 h of transfection with NC-siRNA or PLXNC1-siRNA, CRC cells invading the Matrigel in Transwell chambers were performed. Note: Scale bars = 200 μm. (E) Representative images of EdU-stained (red) cells and the quantification of cell proliferation ratio normalized to Hoechst-stained (blue) cells. Scale bars = 75 μm. (F) qRT-PCR data of the PLXNC1 expression in LoVo cells following transfection with PLXNC1 plasmids or controls. GAPDH was a normalization control. (G) CCK-8 assay results show the viability of LoVo cells following transfection with PLXNC1 plasmids or controls. (H, I) Transwell assay was employed to count the number of migrated (H) and invaded (I) LoVo cells following transfection with PLXNC1 plasmids or controls. ∗∗∗ p < 0.001; ∗∗ p < 0.01, and ∗ p < 0.05.
    Cck 8 Reagent, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cck-8+reagent/8+cck/pm42302478-79-24-26
    Average 86 stars, based on 1 article reviews
    cck 8 reagent - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    Image Search Results


    PLXNC1 promotes the proliferation, migration, and invasion of colorectal cancer (CRC) cells in vitro. (A) qRT-PCR analysis was conducted to examine the knockdown efficiency of PLXNC1 in the negative control (NC)-siRNA- or PLXNC1-siRNA-transfected CRC cells. NC-siRNA was used as a negative control. GAPDH was a normalization control. (B) CCK-8 assay was performed to assay the viability of control and PLXNC1-silenced CRC cells. (C) After 48 h of transfection with NC-siRNA or PLXNC1-siRNA, the migration of CRC cells in Transwell chambers was determined. (D) After 48 h of transfection with NC-siRNA or PLXNC1-siRNA, CRC cells invading the Matrigel in Transwell chambers were performed. Note: Scale bars = 200 μm. (E) Representative images of EdU-stained (red) cells and the quantification of cell proliferation ratio normalized to Hoechst-stained (blue) cells. Scale bars = 75 μm. (F) qRT-PCR data of the PLXNC1 expression in LoVo cells following transfection with PLXNC1 plasmids or controls. GAPDH was a normalization control. (G) CCK-8 assay results show the viability of LoVo cells following transfection with PLXNC1 plasmids or controls. (H, I) Transwell assay was employed to count the number of migrated (H) and invaded (I) LoVo cells following transfection with PLXNC1 plasmids or controls. ∗∗∗ p < 0.001; ∗∗ p < 0.01, and ∗ p < 0.05.

    Journal: Genes & Diseases

    Article Title: Identification of PLXNC1 as a novel biomarker for consensus molecular subtype 4 in colorectal cancer

    doi: 10.1016/j.gendis.2025.101974

    Figure Lengend Snippet: PLXNC1 promotes the proliferation, migration, and invasion of colorectal cancer (CRC) cells in vitro. (A) qRT-PCR analysis was conducted to examine the knockdown efficiency of PLXNC1 in the negative control (NC)-siRNA- or PLXNC1-siRNA-transfected CRC cells. NC-siRNA was used as a negative control. GAPDH was a normalization control. (B) CCK-8 assay was performed to assay the viability of control and PLXNC1-silenced CRC cells. (C) After 48 h of transfection with NC-siRNA or PLXNC1-siRNA, the migration of CRC cells in Transwell chambers was determined. (D) After 48 h of transfection with NC-siRNA or PLXNC1-siRNA, CRC cells invading the Matrigel in Transwell chambers were performed. Note: Scale bars = 200 μm. (E) Representative images of EdU-stained (red) cells and the quantification of cell proliferation ratio normalized to Hoechst-stained (blue) cells. Scale bars = 75 μm. (F) qRT-PCR data of the PLXNC1 expression in LoVo cells following transfection with PLXNC1 plasmids or controls. GAPDH was a normalization control. (G) CCK-8 assay results show the viability of LoVo cells following transfection with PLXNC1 plasmids or controls. (H, I) Transwell assay was employed to count the number of migrated (H) and invaded (I) LoVo cells following transfection with PLXNC1 plasmids or controls. ∗∗∗ p < 0.001; ∗∗ p < 0.01, and ∗ p < 0.05.

    Article Snippet: CCK-8 reagent (10 μL, DOJINDO, Kumamoto, Japan) was added to each well at 0, 24, 48, and 72 h after transfection and incubated at 37 °C for 4 h. Absorbance at 450 nm was measured using a microplate reader (PerkinElmer EnVision, Massachusetts, USA).

    Techniques: Migration, In Vitro, Quantitative RT-PCR, Knockdown, Negative Control, Transfection, Control, CCK-8 Assay, Staining, Expressing, Transwell Assay